{"id":1170174,"title":"DSEN Abstract: Safety, effectiveness, and cost-effectiveness of long-acting versus intermediate-acting insulin for patients with type 1 diabetes: a systematic review and network meta-analysis - CIHR","sourceCode":"cihr","sourceName":"Canadian Institutes of Health Research","language":"en","captureDate":"2026-04-12","captureTimestamp":"2026-04-12T21:46:10.461000+00:00","jobId":8,"originalUrl":"https://cihr-irsc.gc.ca/e/51394.html?wbdisable=true","snippet":"DSEN Abstract Safety, effectiveness, and cost-effectiveness of long-acting versus intermediate-acting insulin for patients with type 1 diabetes: a systematic review and network meta-analysis This research was funded by the Drug Safety and Effectiveness Network (DSEN) and…","rawSnapshotUrl":"/api/snapshots/raw/1170174","browseUrl":"https://replay.healtharchive.ca/job-8/20260412214610/https://cihr-irsc.gc.ca/e/51394.html?wbdisable=true#ha_snapshot=1170174","mimeType":"text/html","statusCode":200,"captureBackend":"browsertrix","captureFidelity":"high"}